Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Acquisitions (2020 - 2021)

Historic Acquisitions for Insight Molecular Diagnostics (IMDX) over the last 2 years, with Q1 2021 value amounting to $607000.0.

  • Insight Molecular Diagnostics' Acquisitions fell 9019.23% to $607000.0 in Q1 2021 from the same period last year, while for Dec 2021 it was $607000.0, marking a year-over-year decrease of 9019.23%. This contributed to the annual value of $607000.0 for FY2021, which is 9019.23% down from last year.
  • Per Insight Molecular Diagnostics' latest filing, its Acquisitions stood at $607000.0 for Q1 2021, which was down 9019.23% from $6.2 million recorded in Q1 2020.
  • Over the past 5 years, Insight Molecular Diagnostics' Acquisitions peaked at $6.2 million during Q1 2020, and registered a low of $607000.0 during Q1 2021.